You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Third-line regimen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV/AIDS Trial in Phnom Penh (Dolutegravir + Darunavir/ritonavir + optimized NRTI)

Recruiting
  • HIV/AIDS
  • Dolutegravir + Darunavir/ritonavir + optimized NRTI
  • Phnom Penh, Cambodia
    NCHADS
Aug 25, 2021

Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Fruquintinib Combined With Chemotherapy
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jun 29, 2023

Advanced Cervical Cancer Trial in Shanghai (Capecitabine, camrelizumab)

Recruiting
  • Advanced Cervical Cancer
  • Capecitabine, camrelizumab
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Jan 27, 2021

Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab and irinotecan
  • (no location specified)
Jul 26, 2023

TAS-102 in Combination With Regorafenib or Fruquintinib for

Not yet recruiting
  • TAS 102
  • +3 more
  • (no location specified)
Aug 7, 2023

Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With

Not yet recruiting
  • Third-line Treatment
  • +2 more
  • furquimatinib and sintilimab
  • (no location specified)
Mar 30, 2023

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

Recruiting
  • Brain Metastases
  • Non-small Cell Lung Cancer
  • EGFR-TK Inhibitor
  • Stereotactic radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 27, 2023

Colorectal Cancer Trial in Shanghai (serplulimab, Fruquintinib)

Not yet recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 13, 2023

Colorectal Tumors Malignant Trial in Shanghai (Tislelizumab Combined With Cetuximab and Irinotecan, Third-line regimens)

Not yet recruiting
  • Colorectal Neoplasms Malignant
  • Tislelizumab Combined With Cetuximab and Irinotecan
  • Third-line regimens
  • Shanghai, Shanghai, China
    Tianshu Liu
Apr 18, 2022

Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

Recruiting
  • Mesotheliomas Pleural
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023

OR Regimen Refractory Marginal Zone Lymphoma Trial (obrutinib, rituximab)

Not yet recruiting
  • OR Regimen Refractory Marginal Zone Lymphoma
  • obrutinib, rituximab
  • (no location specified)
Nov 12, 2023

Metastatic Colorectal Cancer Trial in Wuhan (SBRT, Fruquintinib, Cadonilimab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • SBRT, Fruquintinib, Cadonilimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

Cancer of Colon Trial in Jerusalem (Cetuximab)

Terminated
  • Cancer of Colon
  • Jerusalem, Israel
    Hadassah Ein Kerem
Aug 2, 2022

Pancreatic Tumors Trial in Guangzhou (Surufatinib, TAS-102)

Not yet recruiting
  • Pancreatic Neoplasms
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Jul 28, 2022

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
  • SHR-A1811
  • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
  • (no location specified)
Nov 6, 2023

Regorafenib, Raltitrexed, Colorectal Tumors Trial (Regorafenib, Raltitrexed)

Not yet recruiting
  • Regorafenib
  • +3 more
  • (no location specified)
Jun 24, 2022

Ustekinumab and Tofacitinib as Third Line Therapy inMulticenter

Completed
  • Ulcerative Colitis
  • Milano, Italy
    Mariangela Allocca
Feb 13, 2023

Metastatic Colorectal Cancer Trial in Bronx, Houston (AlloStim)

Recruiting
  • Metastatic Colorectal Cancer
  • AlloStim
  • Florham Park, New Jersey
  • +1 more
Aug 30, 2022

Colorectal Cancer Trial in Shanghai (VIC, Bevacizumab Plus Chemotherapy)

Recruiting
  • Colorectal Cancer
  • VIC
  • Bevacizumab Plus Chemotherapy
  • Shanghai, China
    Department of General Surgery, Zhongshan Hospital, Fudan Univers
Sep 14, 2022

Metastatic Colorectal Cancer Trial in Cairo (FOLFOXIRI Protocol)

Completed
  • Metastatic Colorectal Cancer
  • FOLFOXIRI Protocol
  • Cairo, El Manial, Egypt
    Kasr El AiniH
Mar 30, 2022

Advanced Colorectal Carcinoma, Liver Metastasis Colon Cancer Trial in Beijing (Fruquintinib, Hepatic Arterial Infusion

Recruiting
  • Advanced Colorectal Carcinoma
  • Liver Metastasis Colon Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jun 1, 2022

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

Immunotherapy, Colorectal Cancer Trial in Fuzhou (Tislelizumab, bevacizumab, TAS-102)

Recruiting
  • Immunotherapy
  • Colorectal Cancer
  • Fuzhou, Fujian, China
  • +1 more
Jul 20, 2022

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023